PMC8645548_01
PMC8645548_02
PMC8645548_03
PMC8645548_04
PMC8645548_05
Evolution of the PANSS negative subscale scores during cariprazine treatment.
fpsyt-12-786171-g0001.jpg
PMC8645548_05_fpsyt-12-786171-g0001.jpg
F1
After 12 weeks of cariprazine 6 mg/day, the positive subscale of PANSS showed a relatively stable level, but the negative subscale mean score decreased with 22% (Figure 1).
Evolution of the PANSS total scores during cariprazine treatment.
fpsyt-12-786171-g0002.jpg
PMC8645548_05_fpsyt-12-786171-g0002.jpg
F2
The overall PANSS mean score decreased by 19.5% (Figure 2), the CGI-S mean scores improved by 15.4% (Figure 3), while the mean GAF scores increased by 17%.
Evolution of the CGI-S scores during cariprazine treatment.
fpsyt-12-786171-g0003.jpg
PMC8645548_05_fpsyt-12-786171-g0003.jpg
F3
The overall PANSS mean score decreased by 19.5% (Figure 2), the CGI-S mean scores improved by 15.4% (Figure 3), while the mean GAF scores increased by 17%.